Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy

Stopped early · Phase 3

Conditions studied: Venous Thrombosis

In brief

This is a randomized trial to compare intermittent compression devices with or without post-operative Arixtra (fondaparinux sodium) in women undergoing major abdominal surgery for known or presumed gynecologic malignancies. This trial seeks to determine if there is a difference in the rate of deep venous thrombosis between these two groups.

Key facts

Study ID
NCT00539942
Run by
University of Alabama at Birmingham
People needed
7
Starts
2007-04-01
Expected to finish
2010-06-01
Last updated by the study team
2017-03-27

Who can join

Age: 19 and older, up to 85. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.